Search for: "Sanofi-Aventis US LLC"
Results 41 - 60
of 84
Sorted by Relevance
|
Sort by Date
10 Jun 2010, 3:58 am
Kappos (Patent Docs) Products Allegra (Fexofenadine) - US: Patent infringement complaint following a Paragraph IV certification: Sanofi-Aventis U.S. [read post]
11 Dec 2019, 8:40 am
Zantac Class Action Lawsuits Recently, two class-action lawsuits were filed against Zantac manufacturer Sanofi-Aventis LLC and Boehringer Ingelheim Pharmaceuticals, who previously held rights to Zantac, with plaintiffs claiming that the companies knowingly put patient health at risk. [read post]
10 Oct 2016, 2:59 pm
Because permanent alopecia should have been announced by Sanofi-Aventis since day one, its absence from the label constituted grounds for action. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma… [read post]
22 Feb 2012, 7:37 am
GmbH and Sanofi-aventis v. [read post]
29 Jun 2011, 3:34 am
Cipla (Spicy IP) Effexor (Venlafaxine) – US: Intellipharmaceutics announces settlement for its generic version of Effexor (GenericsWeb) Eloxatin (Oxaliplatin) – US: Patent infringement complaint in response to Para IV certification: Sanofi-Aventis U.S. [read post]
5 May 2010, 4:46 am
(Patent Docs) Plavix (Clopidogrel) – Netherlands: District Court of The Hague finds Sanofi-Aventis’ patent invalid for lack of inventive step in proceedings brought by RatioPharm (EPLAW) Rapamune (Sirolimus) – US: Patent infringement complaint following Paragraph IV certification: Pfizer Inc. et al. v. [read post]
25 Aug 2017, 7:02 am
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
25 Aug 2017, 7:02 am
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
25 Aug 2010, 12:37 am
USPTO – Briefing schedule update (Patent Docs) US: Patent expiration, pediatric exclusivity, and generic drug approval – Some interesting tensions between the FDC Act and patent law (FDA Law Blog) Products Androderm (Testosterone) – US: False marking complaint based on Watson’s marking of its Androderm products: Promote Innovation LLC v. [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) US: District Court M D North Carolina: $4.8 million attorneys’ fee award designed to reimburse not punish: Aventis CropScience v. [read post]
16 Aug 2011, 11:35 pm
General Medicines Patent Pool faces licensing issues (Spicy IP) Australia: Pharmaceuticals – copyright in PIs and indirect patent infringement: Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) (Mallesons) China: One out of three seeds in China infringes patents (IP Dragon) EU: More comments to the AG opinion in Medeva (The SPC Blog) EU: Patent term extensions – uncertainty and disharmony: an overview (The SPC Blog) India: NGO alleges… [read post]
10 Jul 2011, 11:29 pm
., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
27 Feb 2009, 5:00 am
(Patent Docs) Lexapro (Escitalopram) – US: Supreme Court refuses to hear appeal from Forest Lab’s allowing Caraco to continue bid to invalidate Lexapro patent despite Forest’s earlier covenant to sue (Law360) (Hal Wegner) Lotrel (Amlodipine) – US: Par and Novartis settle Lotrel lawsuit (Patent Docs) (GenericsWeb) Lovenox (Enoxaparin) – US: Amphastar antitrust claims nixed in Lovenox suit against… [read post]
5 Feb 2012, 8:04 am
See Sanofi-Aventis chemist admits trade secret theft. [read post]
1 Mar 2016, 1:32 pm
Sanofi-Aventis U.S., LLC, No. 13-17390, slip op. [read post]
25 Jan 2009, 2:36 pm
The last big pharmaceutical industry acquisition came in August 2004, when Paris-based Sanofi-Synthelabo acquired Aventis SA of Strasburg, France, for $64.4 billion to create Sanofi Aventis SA, France's largest drugmaker. [read post]
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
